John N. Abelson

Fondatore presso The Agouron Institute

Consumer Services

Health Technology

Profilo

John N.
Abelson is the founder of Melinta Subsidiary Corp.
which was founded in 2000.
Dr. Abelson is also the founder of The Agouron Institute.
Currently, Dr. Abelson holds the position of Professor-Emeritus at California Institute of Technology.

Posizioni attive di John N. Abelson

Società	Posizione	Inizio
California Institute of Technology California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.	Corporate Officer/Principal	-
The Agouron Institute	Fondatore	-

Tutte le posizioni attive di John N. Abelson

Precedenti posizioni note di John N. Abelson

Società	Posizione	Fine
Melinta Subsidiary Corp. Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT.	Fondatore	-

Vedi nel dettaglio l'esperienza di John N. Abelson

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di John N. Abelson

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Melinta Subsidiary Corp. Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT.	Health Technology
The Agouron Institute